Freeman Kevin Lee bought HCAT
February 20, 2024 · Form 4 insider transaction
Freeman Kevin Lee bought 110,000 shares of Health Catalyst, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
110,000
Price
$0.00
Total value
N/A
InsiderFreeman Kevin Lee
RoleOfficer
CompanyHealth Catalyst, Inc. (HCAT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2024
Filing dateFebruary 22, 2024
Shares owned after277,810
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.